YORK, Pa., Oct. 31, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2014 first quarter ended September 30, 2013 after market trading ends on Monday, November 11, 2013.
Management has scheduled a conference call for 4:30 p.m. U.S. EST on Monday, November 11, 2013 (Tuesday, November 12, 2013 at 8:30 a.m. AEDT), to review the Company's financial results, commercial partnerships, and future outlook. The conference call will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. Listeners are urged to login approximately 20 minutes before the conference call is scheduled to begin in order to register, as well as download and install any necessary audio software. An archive of the webcast will be available on the Company's website.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's broad portfolio of proprietary device technologies includes prefilled syringes with automatic needle retraction, reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Each of these innovative and highly differentiated device platforms can be customized by Unilife to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.
General: UNIS-G
|
Investor Contacts (US):
|
Analyst Enquiries
|
Investor Contacts (Australia)
|
|
Todd Fromer / Garth Russell
|
Lynn Pieper
|
Jeff Carter
|
|
KCSA Strategic Communications
|
Westwicke Partners
|
Unilife Corporation
|
|
P: + 1 212-896-1215 / 212-896-1250
|
P: + 1 415-202-5678
|
P: + 61 2 8346 6500
|
SOURCE Unilife Corporation
